IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

BVF Inc

Q3 2016 Holdings

Filed 2016-11-14 | 29 holdings | $55.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Cytokinetics Inc(CYTK)COM NEW23282W605$45.9M4,997,07182.5%
Cytomx Therapeutics Inc(CTMX)COM23284F105$9.3M591,81316.7%
Blueprint Medicines Corp(2L9)COM09627Y109$82.1K2,765,0800.1%
Chemocentryx Inc(CCXIEUR)COM16383L106$48.7K8,064,0190.1%
Array Biopharma Inc(ARRYEUR)COM04269X105$43.6K6,461,1860.1%
Cascadian Therapeutics IncCOM14740B101$30.8K18,799,3680.1%
Forward Pharma A/SSPONSORED ADR34986J105$29.1K1,387,8530.1%
Colucid Pharmaceuticals IncCOM19716T101$29.1K763,3000.1%
Concert Pharmaceuticals Inc(CNCEEUR)COM206022105$27.5K2,723,2100.0%
Xenon Pharmaceuticals Inc(XENE)COM98420N105$25.2K3,108,9050.0%
Oncomed Pharmaceuticals IncCOM68234X102$20.7K1,812,0050.0%
Glycomimetics Inc(GLYCEUR)COM38000Q102$17.3K2,426,2820.0%
CTI Biopharma CorpCOM12648L106$16.8K44,796,9400.0%
Tobira Therapeutics IncCOM88883P101$15.9K399,4330.0%
Nivalis Therapeutics IncCOM65481J109$13.9K1,709,6730.0%
Arqule Inc(ARQLUSD)COM04269E107$13.2K7,400,1280.0%
Immune Design CorpCOM45252L103$9.1K1,200,0000.0%
GTX Inc delCOM40052B108$9.0K11,512,0000.0%
Infinity Pharmaceuticals Inc(INFIQ)COM45665G303$8.0K5,149,6440.0%
Protagonist Therapeutics Inc(PTGX)COM74366E102$7.9K375,0000.0%
Esperion Therapeutics Inc NE(ESPR)COM29664W105$6.8K493,8720.0%
Aduro Biotech Inc(ADROEUR)COM00739L101$6.2K501,1550.0%
Sunesis Pharmaceuticals IncCOM PAR867328700$3.2K730,3610.0%
Orexigen Therapeutics IncNOTE 2.750%12/0686164AB0$2.7K$10,000,0000.0%
Orexigen Therapeutics IncCOM NEW686164302$2.4K734,9760.0%
Pain Therapeutics IncCOM69562K100$2.3K2,278,5520.0%
Pieris Pharmaceuticals IncCOM720795103$1.9K1,016,5930.0%
Catalyst Biosciences IncCOM14888D109$1.0K865,7730.0%
Globeimmune Inc(GBIM)COM37957B100$822657,6530.0%